These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
378 related items for PubMed ID: 18577180
1. Mutations in the multi-drug resistance regulator MRR1, followed by loss of heterozygosity, are the main cause of MDR1 overexpression in fluconazole-resistant Candida albicans strains. Dunkel N, Blass J, Rogers PD, Morschhäuser J. Mol Microbiol; 2008 Aug; 69(4):827-40. PubMed ID: 18577180 [Abstract] [Full Text] [Related]
10. The transcription factor Ndt80 does not contribute to Mrr1-, Tac1-, and Upc2-mediated fluconazole resistance in Candida albicans. Sasse C, Schillig R, Dierolf F, Weyler M, Schneider S, Mogavero S, Rogers PD, Morschhäuser J. PLoS One; 2011 Sep; 6(9):e25623. PubMed ID: 21980509 [Abstract] [Full Text] [Related]
11. Activation of the multiple drug resistance gene MDR1 in fluconazole-resistant, clinical Candida albicans strains is caused by mutations in a trans-regulatory factor. Wirsching S, Michel S, Köhler G, Morschhäuser J. J Bacteriol; 2000 Jan; 182(2):400-4. PubMed ID: 10629186 [Abstract] [Full Text] [Related]
12. Palmarumycin P3 Reverses Mrr1-Mediated Azole Resistance by Blocking the Efflux Pump Mdr1. Song M, Zhang M, Lu J, Xie F, Song J, Luan X, Hou X, Lou H, Chang W. Antimicrob Agents Chemother; 2022 Mar 15; 66(3):e0212621. PubMed ID: 35041505 [Abstract] [Full Text] [Related]
13. An acquired mechanism of antifungal drug resistance simultaneously enables Candida albicans to escape from intrinsic host defenses. Hampe IAI, Friedman J, Edgerton M, Morschhäuser J. PLoS Pathog; 2017 Sep 15; 13(9):e1006655. PubMed ID: 28953977 [Abstract] [Full Text] [Related]
14. Induction of Candida albicans drug resistance genes by hybrid zinc cluster transcription factors. Schneider S, Morschhäuser J. Antimicrob Agents Chemother; 2015 Jan 15; 59(1):558-69. PubMed ID: 25385116 [Abstract] [Full Text] [Related]
15. Molecular mechanisms of drug resistance in clinical Candida species isolated from Tunisian hospitals. Eddouzi J, Parker JE, Vale-Silva LA, Coste A, Ischer F, Kelly S, Manai M, Sanglard D. Antimicrob Agents Chemother; 2013 Jul 15; 57(7):3182-93. PubMed ID: 23629718 [Abstract] [Full Text] [Related]
16. Multiple cis-acting sequences mediate upregulation of the MDR1 efflux pump in a fluconazole-resistant clinical Candida albicans isolate. Hiller D, Stahl S, Morschhäuser J. Antimicrob Agents Chemother; 2006 Jul 15; 50(7):2300-8. PubMed ID: 16801405 [Abstract] [Full Text] [Related]
17. Targeted gene disruption in Candida albicans wild-type strains: the role of the MDR1 gene in fluconazole resistance of clinical Candida albicans isolates. Wirsching S, Michel S, Morschhäuser J. Mol Microbiol; 2000 May 15; 36(4):856-65. PubMed ID: 10844673 [Abstract] [Full Text] [Related]
18. Differential requirement of the transcription factor Mcm1 for activation of the Candida albicans multidrug efflux pump MDR1 by its regulators Mrr1 and Cap1. Mogavero S, Tavanti A, Senesi S, Rogers PD, Morschhäuser J. Antimicrob Agents Chemother; 2011 May 15; 55(5):2061-6. PubMed ID: 21343453 [Abstract] [Full Text] [Related]
19. An A643T mutation in the transcription factor Upc2p causes constitutive ERG11 upregulation and increased fluconazole resistance in Candida albicans. Heilmann CJ, Schneider S, Barker KS, Rogers PD, Morschhäuser J. Antimicrob Agents Chemother; 2010 Jan 15; 54(1):353-9. PubMed ID: 19884367 [Abstract] [Full Text] [Related]
20. [Investigation of the expression levels of efflux pumps in fluconazole-resistant Candida albicans isolates]. Gulat S, Doluca Dereli M. Mikrobiyol Bul; 2014 Apr 15; 48(2):325-34. PubMed ID: 24819270 [Abstract] [Full Text] [Related] Page: [Next] [New Search]